Arcus Biosciences RCUS Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's operating income?
- Arcus Biosciences (RCUS) reported operating income of -$134M in Q1 2026.
- How has Arcus Biosciences's operating income changed year-over-year?
- Arcus Biosciences's operating income decreased by 9.8% year-over-year, from -$122M to -$134M.
- What is the long-term trend for Arcus Biosciences's operating income?
- Over 4 years (2021 to 2025), Arcus Biosciences's operating income has grown at a 63.5% compound annual growth rate (CAGR), from $54M to -$386M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.